DermAvance Pharmaceuticals Inc – Trademark Portfolio
Entity Type: 03
DermAvance Pharmaceuticals Inc holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TRET-A and HYDRO-Q 4% GEL. The owner is based in Malvern, PA.
Suite 200
274 West Lancaster Ave
Malvern, PA 19355
Showing of trademarks Trademarks
Trademark Classifications
DermAvance Pharmaceuticals Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does DermAvance Pharmaceuticals Inc have?
DermAvance Pharmaceuticals Inc has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 1 cancelled.
What trademark classes does DermAvance Pharmaceuticals Inc file in?
DermAvance Pharmaceuticals Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DermAvance Pharmaceuticals Inc's most well-known trademarks?
DermAvance Pharmaceuticals Inc's registered trademark portfolio includes well-known marks such as TRET-A and HYDRO-Q 4% GEL. These are among 2 currently registered trademarks in the portfolio.
What is DermAvance Pharmaceuticals Inc's trademark registration success rate?
DermAvance Pharmaceuticals Inc has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.